US Patent 10980741 Compositions and methods for treating pterygium recurrence
Patent 10980741 was granted and assigned to CLOUDBREAK THERAPEUTICS LLC on April, 2021 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10980741 Compositions and methods for treating pterygium recurrence
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.